PLUVICTO-Induced Radiation Nephritis Presenting as Thrombotic Microangiopathy (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-PO0719; Pres time: Oct 22, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "This case highlights the need for vigilant renal monitoring in patients receiving 177Lu-PSMA therapy, particularly those with baseline renal risk factors. Individualized radionuclide dosing and closer surveillance beyond serum creatinine, including routine urinalysis or biomarkers such as NGAL, may allow earlier detection of kidney injury and improved outcomes."
Castration-Resistant Prostate Cancer • Chronic Kidney Disease • Fibrosis • Genito-urinary Cancer • Hypertension • Immunology • Nephrology • Prostate Cancer • Renal Disease • Solid Tumor
|
|
Cherylene S. Abalos; Rahmin A. Rabenou; Eric Brucks
|